{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:10:51Z","timestamp":1793689851777,"version":"4.5.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jconrel.2025.02.037","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T15:15:12Z","timestamp":1740064512000},"page":"910-926","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Sustained release of a novel non-fibrate PPAR\u03b1 agonist from microparticles for neuroprotection in murine models of age-related macular degeneration"],"prefix":"10.1016","volume":"380","author":[{"given":"Yi","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagun","family":"Poudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaolong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn G.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Duerfeldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-xing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.02.037_bb0005","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","article-title":"Consensus nomenclature for reporting Neovascular age-related macular degeneration data: consensus on Neovascular age-related macular degeneration nomenclature study group","volume":"127","author":"Spaide","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100858","article-title":"Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration","volume":"79","author":"Kaarniranta","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0015","article-title":"Anti-vascular endothelial growth factor biosimilars for neovascular age-related macular degeneration","volume":"6","author":"Sunaga","year":"2024","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0020","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.ophtha.2013.01.061","article-title":"Emerging therapies for neovascular age-related macular degeneration: drugs in the pipeline","volume":"120","author":"Kaiser","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0025","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1021\/acsmedchemlett.3c00056","article-title":"Design, Synthesis, and Structure-Activity Relationships of Biaryl Anilines as Subtype-Selective PPAR-alpha Agonists","volume":"14","author":"Lee","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108617","article-title":"The role of peroxisome proliferator-activated receptors in healthy and diseased eyes","volume":"208","author":"Escandon","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0035","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(07)61607-9","article-title":"F.S. Investigators, effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial","volume":"370","author":"Keech","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0040","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1001288","article-title":"Effects of medical therapies on retinopathy progression in type 2 diabetes","volume":"363","author":"A.S. Group","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239251","article-title":"Small-molecule modulation of PPARs for the treatment of prevalent vascular retinal diseases","volume":"21","author":"Dou","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0050","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1167\/iovs.17-22091","article-title":"Therapeutic effects of PPARalpha agonist on ocular neovascularization in models recapitulating Neovascular age-related macular degeneration","volume":"58","author":"Qiu","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0055","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1021\/acs.molpharmaceut.8b01319","article-title":"Fenofibrate-loaded biodegradable nanoparticles for the treatment of experimental diabetic retinopathy and Neovascular age-related macular degeneration","volume":"16","author":"Qiu","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0060","article-title":"Therapeutic effects of Fenofibrate Nano-emulsion eye drops on retinal vascular leakage and neovascularization","volume":"10","author":"Huang","year":"2021","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2337\/db11-0413","article-title":"Therapeutic effects of PPARalpha agonists on diabetic retinopathy in type 1 diabetes models","volume":"62","author":"Chen","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0070","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1021\/acs.jmedchem.9b01189","article-title":"Evolution of a 4-Benzyloxy-benzylamino Chemotype to provide efficacious, potent, and isoform selective PPARalpha agonists as leads for retinal disorders","volume":"63","author":"Dou","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.actbio.2019.07.054","article-title":"Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization","volume":"97","author":"Kim","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0080","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41467-020-14340-x","article-title":"Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles","volume":"11","author":"Tsujinaka","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0085","article-title":"Long-acting microparticle formulation of Griseofulvin for ocular neovascularization therapy","volume":"20","author":"Chobisa","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0090","series-title":"Hanes Sustained Delivery of Therapeutic Agents to an Eye Compartment, in, United States","author":"Peter","year":"2014"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114342","article-title":"Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologies","volume":"187","author":"Alshaikh","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0100","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1167\/iovs.07-0870","article-title":"Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model\u2019s retinal angiomatous proliferation","volume":"49","author":"Hu","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0105","doi-asserted-by":"crossref","first-page":"34420","DOI":"10.1074\/jbc.M611289200","article-title":"Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization","volume":"282","author":"Chen","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mvr.2009.02.005","article-title":"Photoreceptor degeneration and retinal inflammation induced by very low-density lipoprotein receptor deficiency","volume":"78","author":"Chen","year":"2009","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nchembio.759","article-title":"Primary amines protect against retinal degeneration in mouse models of retinopathies","volume":"8","author":"Maeda","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0120","doi-asserted-by":"crossref","first-page":"26684","DOI":"10.1074\/jbc.M804505200","article-title":"Retinopathy in mice induced by disrupted all-trans-retinal clearance","volume":"283","author":"Maeda","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208399","article-title":"Neuroprotective effects of PPARalpha in retinopathy of type 1 diabetes","volume":"14","author":"Pearsall","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0130","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/jop.2015.0049","article-title":"A simple optical coherence tomography quantification method for choroidal neovascularization","volume":"31","author":"Sulaiman","year":"2015","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/cells11233869","article-title":"The protective role of microglial PPARalpha in diabetic retinal neurodegeneration and neurovascular dysfunction","volume":"11","author":"Yuan","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0140","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/01926230290105721","article-title":"Fixation of testes and eyes using a modified Davidson\u2019s fluid: comparison with Bouin\u2019s fluid and conventional Davidson\u2019s fluid","volume":"30","author":"Latendresse","year":"2002","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0145","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.freeradbiomed.2010.08.024","article-title":"H2O2-induced mitochondrial fragmentation in C2C12 myocytes","volume":"49","author":"Fan","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0150","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1167\/iovs.04-0653","article-title":"Downregulation of cone-specific gene expression and degeneration of cone photoreceptors in the Rpe65\u2212\/\u2212 mouse at early ages","volume":"46","author":"Znoiko","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-60327-409-8_1","article-title":"In situ detection of apoptosis by the TUNEL assay: an overview of techniques","volume":"682","author":"Loo","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0160","doi-asserted-by":"crossref","first-page":"6701","DOI":"10.1167\/iovs.15-17599","article-title":"A novel ImageJ macro for automated cell death quantitation in the retina","volume":"56","author":"Maidana","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0165","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.2337\/db18-1278","article-title":"A protective effect of PPARalpha in endothelial progenitor cells through regulating metabolism","volume":"68","author":"Shao","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0170","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1083\/jcb.119.6.1681","article-title":"Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter","volume":"119","author":"Al-Ubaidi","year":"1992","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0175","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/path.2611","article-title":"Muller cell-derived VEGF is a significant contributor to retinal neovascularization","volume":"219","author":"Bai","year":"2009","journal-title":"J. Pathol."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0180","doi-asserted-by":"crossref","first-page":"15401","DOI":"10.1073\/pnas.1307211110","article-title":"Pathogenic role of diabetes-induced PPAR-alpha down-regulation in microvascular dysfunction","volume":"110","author":"Hu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0185","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.expneurol.2012.08.029","article-title":"Electrical stimulation ameliorates light-induced photoreceptor degeneration in vitro via suppressing the proinflammatory effect of microglia and enhancing the neurotrophic potential of Muller cells","volume":"238","author":"Zhou","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-1-60761-411-1_4","article-title":"Identification of ROS using oxidized DCFDA and flow-cytometry","volume":"594","author":"Eruslanov","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0195","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1080\/10717544.2017.1370620","article-title":"Subretinal delivery of erythropoietin alleviates the N-methyl-N-nitrosourea-induced photoreceptor degeneration and visual functional impairments: an in vivo and ex vivo study","volume":"24","author":"Tao","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164419","article-title":"Multi-functional OCT enables longitudinal study of retinal changes in a VLDLR knockout mouse model","volume":"11","author":"Augustin","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0205","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12915-017-0451-x","article-title":"PPARalpha is essential for retinal lipid metabolism and neuronal survival","volume":"15","author":"Pearsall","year":"2017","journal-title":"BMC Biol."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0210","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1084\/jem.20161645","article-title":"Inflammatory signals from photoreceptor modulate pathological retinal angiogenesis via c-Fos","volume":"214","author":"Sun","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0215","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1074\/jbc.M111.315432","article-title":"Mechanism of all-trans-retinal toxicity with implications for stargardt disease and age-related macular degeneration","volume":"287","author":"Chen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0220","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1167\/iovs.14-14136","article-title":"Fundus autofluorescence and photoreceptor cell rosettes in mouse models","volume":"55","author":"Flynn","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0225","doi-asserted-by":"crossref","first-page":"15326","DOI":"10.1074\/jbc.M112.448712","article-title":"Photoreceptor proteins initiate microglial activation via toll-like receptor 4 in retinal degeneration mediated by all-trans-retinal","volume":"288","author":"Kohno","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0230","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.preteyeres.2017.03.002","article-title":"The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD","volume":"60","author":"Datta","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102840","article-title":"Comparative mechanistic study of RPE cell death induced by different oxidative stresses","volume":"65","author":"Tong","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102038","article-title":"Mechanisms of impaired mitochondrial homeostasis and NAD(+) metabolism in a model of mitochondrial heart disease exhibiting redox active iron accumulation","volume":"46","author":"Chiang","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0245","article-title":"Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration","volume":"5","author":"Li","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0250","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0255","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","article-title":"Vascular endothelial growth factor-a is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury","volume":"171","author":"Nishijima","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0260","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/jamaophthalmol.2020.0437","article-title":"Incidence and progression of nongeographic atrophy in the comparison of age-related macular degeneration treatments trials (CATT) clinical trial","volume":"138","author":"Daniel","year":"2020","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0265","first-page":"1857","article-title":"Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review","volume":"10","author":"Yang","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0270","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.survophthal.2023.01.007","article-title":"Effects of systemic drugs on the development and progression of age-related macular degeneration","volume":"68","author":"Grimes","year":"2023","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0275","first-page":"47","article-title":"A review of currently available Fenofibrate and Fenofibric acid formulations","volume":"4","author":"Ling","year":"2013","journal-title":"Cardiol. Res."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0280","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1021\/jm9016812","article-title":"Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453)","volume":"53","author":"Li","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119339","article-title":"The effect of PLGA molecular weight differences on risperidone release from microspheres","volume":"582","author":"Kohno","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0290","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0295","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1039\/D1NR02065J","article-title":"Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery","volume":"13","author":"Shi","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11070327","article-title":"Chemistry routes for copolymer synthesis containing PEG for targeting, imaging, and drug delivery purposes","volume":"11","author":"Rahme","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0305","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0310","first-page":"19649","article-title":"Multifunctional Nanotherapeutics with long-acting release against macular degeneration by minimally invasive administration","volume":"18","author":"Chang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119935","article-title":"Sustained delivery of acriflavine from the suprachoroidal space provides long term suppression of choroidal neovascularization","volume":"243","author":"Hackett","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0320","article-title":"Considerations for polymers used in ocular drug delivery","volume":"8","author":"Allyn","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0325","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029807","article-title":"Results of intravitreal dexamethasone implant (Ozurdex(R)) for retinal vascular diseases with macular edema: An observational study of real-life situations","volume":"101","author":"Jirarattanasopa","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0330","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jconrel.2022.06.036","article-title":"Transitioning from a lab-scale PLGA microparticle formulation to pilot-scale manufacturing","volume":"348","author":"Otte","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0335","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/361724a0","article-title":"Retinal age pigments generated by self-assembling lysosomotropic detergents","volume":"361","author":"Eldred","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0340","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ajo.2022.11.020","article-title":"In vivo longitudinal measurement of cone photoreceptor density in intermediate age-related macular degeneration","volume":"248","author":"Wang","year":"2023","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0345","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1167\/iovs.07-1181","article-title":"Foveal cone-photoreceptor integrity in aging macula disorder","volume":"49","author":"Kanis","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0350","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.732287","article-title":"The relationship between Perifoveal L-cone isolating visual acuity and cone photoreceptor spacing-understanding the transition between healthy aging and early AMD","volume":"13","author":"Baraas","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0355","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nm.4059","article-title":"Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1","volume":"22","author":"Joyal","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0360","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/14728222.2021.1991913","article-title":"Therapeutic potential of PGC-1alpha in age-related macular degeneration (AMD) - the involvement of mitochondrial quality control, autophagy, and antioxidant response","volume":"25","author":"Hyttinen","year":"2021","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jconrel.2025.02.037_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101201","article-title":"Mitochondrial oxidative stress in the retinal pigment epithelium (RPE) led to metabolic dysfunction in both the RPE and retinal photoreceptors","volume":"24","author":"Brown","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.jconrel.2025.02.037_bb0370","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.cmet.2019.09.003","article-title":"Dietary sugars Alter hepatic fatty acid oxidation via transcriptional and post-translational modifications of mitochondrial proteins","volume":"30","author":"Softic","year":"2019","journal-title":"Cell Metab."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925001506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925001506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:53:38Z","timestamp":1770141218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925001506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":74,"alternative-id":["S0168365925001506"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.02.037","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained release of a novel non-fibrate PPAR\u03b1 agonist from microparticles for neuroprotection in murine models of age-related macular degeneration","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.02.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}